Clevidipine: Completed Phase III enrollment

MDCO completed enrollment of 1,500 patients in 3 open-label, U.S. Phase III ECLIPSE trials. The enrollment was halted in March 2005 after preliminary data showed more frequent atrial fibrillation (AF)...